Vimpat -Drug Insights, 2016 Now Available at iData Insights
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Vimp<strong>at</strong></strong> -<strong>Drug</strong> <strong>Insights</strong>, <strong>2016</strong> <strong>Now</strong> <strong>Available</strong> <strong>at</strong> iD<strong>at</strong>a<br />
<strong>Insights</strong><br />
DelveInsight <strong>Drug</strong> Report, <strong>Vimp<strong>at</strong></strong>- <strong>Drug</strong> <strong>Insights</strong>, <strong>2016</strong>highlights the <strong>Vimp<strong>at</strong></strong> marketed details, pipeline<br />
st<strong>at</strong>us and the Global API Manufacturers along with the loc<strong>at</strong>ion. The Delve<strong>Insights</strong> report covers the<br />
Global Market Assessment of the <strong>Vimp<strong>at</strong></strong> covering the total sales estim<strong>at</strong>ion and also provides the<br />
<strong>Vimp<strong>at</strong></strong> sales performance during the historical period and forecast period to 2018. Delve<strong>Insights</strong> Report<br />
also covers the detailed clinical assessment of <strong>Vimp<strong>at</strong></strong>, p<strong>at</strong>ents inform<strong>at</strong>ion and exclusivity d<strong>at</strong>a, route of<br />
synthesis, competitive landscape, and generic players. In addition to this, Delve<strong>Insights</strong> Report provides<br />
the SWOT analysis for the <strong>Vimp<strong>at</strong></strong>. Please note:This report requires certain upd<strong>at</strong>es. We have all the<br />
inform<strong>at</strong>ion available but require 3 business days to complete the process and ensure it is as up-to-d<strong>at</strong>e<br />
as possible. Certain sections in the report may be removed or altered based on the availability and<br />
relevance of d<strong>at</strong>a for the indic<strong>at</strong>ed drug.<br />
Browse Complete Report with TOC @ http://www.id<strong>at</strong>ainsights.com/reports-landingpage.php?id=165844/vimp<strong>at</strong>-drug-insights-<strong>2016</strong><br />
To Get Sample Copy of Report visit http://www.id<strong>at</strong>ainsights.com/reports-landingpage.php?id=165844/vimp<strong>at</strong>-drug-insights-<strong>2016</strong><br />
Table of Contents<br />
1. DelveInsight Report Introduction<br />
2. <strong>Vimp<strong>at</strong></strong> Overview<br />
2.1 Market Competition<br />
2.3 Competitors in Development<br />
3 Global Sales Assessment<br />
3.1 Historical Sales of Somavert<br />
3.2 Forecasted Sales of Somavert<br />
4 Product Description<br />
4.1 Mechanism of Action<br />
4.2 Pharmacodynamic Properties<br />
4.3 Pharmacokinetic Properties<br />
5 Marketed Details<br />
1
5.1 United St<strong>at</strong>es<br />
5.2 Europe<br />
6 P<strong>at</strong>ent Inform<strong>at</strong>ion<br />
6.1 P<strong>at</strong>ent Numbers and Expiry Details<br />
6.2 P<strong>at</strong>ent and Exclusivity Expiry Assessment United St<strong>at</strong>es (US)<br />
6.3 P<strong>at</strong>ent Details<br />
7 Route of Synthesis<br />
8 Global API Manufacturers Assessment<br />
8.1 The United St<strong>at</strong>es <strong>Drug</strong> Master File (US DMF)<br />
8.2 The Europe <strong>Drug</strong> Master File (EUDMF)/Active Substance Master File (ASMF)<br />
8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China<br />
8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India<br />
9 Generic Players<br />
10 The Pipeline Coverage<br />
11 Clinical Trials Inform<strong>at</strong>ion<br />
11.1 Clinical Trials by Zone<br />
12 Company Profile<br />
12.1 Company Summary<br />
12.2 Company Financials<br />
13 SWOT Analysis<br />
14 References<br />
15 Appendix<br />
16 Methodology<br />
2
17 Consulting Services<br />
18 About DelveInsight<br />
19 Contact Us<br />
20 Disclaimer<br />
Read More http://www.id<strong>at</strong>ainsights.com/reports-landing-page.php?id=165844/vimp<strong>at</strong>-drug-insights-<br />
<strong>2016</strong><br />
About Us:<br />
iD<strong>at</strong>a <strong>Insights</strong> which oper<strong>at</strong>es under Precision Research and Consulting Priv<strong>at</strong>e Limited is a leading<br />
market research inform<strong>at</strong>ion aggreg<strong>at</strong>or and marketing research consulting firm. We conduct both<br />
primary and secondary research. Our work does not end with research it is also involved in distributing<br />
reports for different companies . We provide actionable recommend<strong>at</strong>ions and provide our expertise for<br />
business success today and tomorrow. It is our goal to be a partner to our clients in the explor<strong>at</strong>ion and<br />
discovery, and then be their guide in the implement<strong>at</strong>ion of changes th<strong>at</strong> will make a difference to their<br />
bottom line.<br />
ContactUs:<br />
iD<strong>at</strong>a <strong>Insights</strong><br />
Tel: 1-866-237-2965<br />
Web: http://www.id<strong>at</strong>ainsights.com<br />
Email: info@id<strong>at</strong>ainsights.com<br />
About iD<strong>at</strong>a <strong>Insights</strong><br />
We work around the clock until our clients are completely s<strong>at</strong>isfied with their promised results. It is our<br />
mission to provide timely services coupled with acute client care to cre<strong>at</strong>e a long-lasting rel<strong>at</strong>ionship<br />
with you. We deliver on our promise to provide results th<strong>at</strong> are essential to the success of your<br />
company. We believe th<strong>at</strong> by doing so, we will earn the trust of our clients for future project.<br />
3
Change language